Association for Academic SurgeryIncreasing Blood Glucose Variability Heralds Hypoglycemia in the Critically Ill1
Introduction
Hyperglycemia in both the perioperative and intensive care unit (ICU) settings is associated with increased morbidity and mortality among diverse patient populations 1, 2, 3, 4, 5, 6, 7. As a result, the use of intensive insulin therapy (IIT) to control blood glucose has been widely adopted in the ICU setting. Since the first study on IIT and outcomes by Van den Berghe [8], an extensive body of literature has emerged. While the 2001 study showed a decrease in mortality associated with IIT, a number of large randomized studies since that time have not been able to reproduce the benefits in terms of morbidity and mortality 9, 10, 11. A recent meta-analysis showed no significant benefit with the use of IIT when combining all studies [12]. However, a subgroup analysis showed that the data still favor the use of IIT in the surgical ICU population. In this group, IIT still appears to be beneficial in decreasing infectious complications and improving survival 8, 13, 14, 15, 16, 17, 18, 19. However, controversy persists over the appropriate patient population and optimum target range for blood glucose (BG) control. This is due, in part, to concerns over hypoglycemia with tight glucose control (80–110 mg/dL) 9, 11, 12, 20, 21.
A number of factors have been shown to be associated with risk of hypoglycemia, including time on intensive insulin therapy [22], requirement for dialysis, decreases in nutrition provided without concurrent decreases in insulin, diabetes mellitus, sepsis, need for vasopressors, and BMI 23, 24, 25. Hypoglycemia’s contribution to the risk of mortality remains uncertain, due to variability in the severity of hypoglycemia, accuracy of monitoring, time intervals between monitoring (altering the period of hypoglycemia), institutional differences in insulin therapy protocols, and the variability in patient severity of illness and clinical disease state among various studies. Thus, studies have yielded conflicting results 26, 27, 28. While target range for glucose control and insulin protocol type and compliance contribute to hypoglycemic events, patient-specific factors also contribute to the overall risk of hypoglycemia. Recent evidence suggests that BG variability is more strongly associated with mortality than either isolated or mean BG levels in the critically ill patient population 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45. In the outpatient diabetic population, wide fluctuations in BG level and increased BG variability have been associated with hypoglycemia [46]. Whether or not a patient’s blood glucose variability is associated with subsequent hypoglycemia in critically ill patients has not been previously studied. We hypothesized that individual differences in BG variability over time in critically ill surgical patients are associated with hypoglycemia and can be utilized to estimate a patient’s risk of hypoglycemia.
Section snippets
Materials and Methods
A retrospective analysis was performed on a cohort of critically ill surgical patients admitted to the surgical intensive care unit (SICU) of a tertiary care, academic medical center from June 1, 2006 to September 1, 2009. All patients within the SICU receive critical care consultation and management until discharge from the ICU. Patient care management is at the discretion of the ICU attending physician according to established evidence-based practice management guidelines.
This study was
Results
During the study period, a total of 78,136 BG measurements were collected on 1392 patients. After excluding BG measurements taken in the first 12 h after SICU admission and following 6 h gaps in IIT treatment, 66,592 BG measurements (85.2%) remained for analysis and modeling. Hypoglycemia (<50 mg/dL) occurred in 154/1392 patients (11.1%). Demographics and clinical characteristics of those who experienced one or more hypoglycemic events compared with those who did not are displayed in Table 1.
Discussion
The use of IIT to control BG in ICU settings has been fairly widely adopted, particularly in surgical ICUs. Controversy regarding appropriate targets for glycemic control persists and interpretation of the data from various trials are confounded by varying rates of hypoglycemia and hypoglycemia’s possible influence on outcome. In addition, there is considerable controversy surrounding the issue of whether IIT is beneficial or harmful, and to which populations. In surgical patients, the weight
Conclusions
Patients who experience hypoglycemia are characterized by higher BG variability prior to the hypoglycemic event. BG variability increases in the 24 h preceding a hypoglycemic event, and patients with high BG variability are at increased risk of hypoglycemia during the period of time their BG remains highly variable. Prospectively measuring BG variability may provide a means for early identification of high-risk patients on IIT, and provide new diagnostic and therapeutic opportunities to
Acknowledgments
Financial support was provided in part by NIH T32 training grant in Diabetes and Endocrinology 5T32DK007061-35 (RK).
References (56)
- et al.
Stress hyperglycaemia
Lancet
(2009) Diabetes, hyperglycemia, and the cardiac surgery patient: Introduction
Semin Thorac Cardiovasc Surg
(2006)- et al.
Clinical effects of hyperglycemia in the cardiac surgery population: The Portland Diabetic Project
Endocr Pract
(2006) Clinical benefits of tight glycaemic control: Focus on the perioperative setting
Best Pract Res Clin Anaesthesiol
(2009)- et al.
Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
J Thorac Cardiovasc Surg
(2003) - et al.
Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project
Endocr Pract
(2004) - et al.
Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures
Ann Thorac Surg
(1999) - et al.
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery
Ann Thorac Surg
(2010) - et al.
Computer-based insulin infusion protocol improves glycemia control over manual protocol
J Am Med Inform Assoc
(2007) - et al.
Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy
Endocr Pract
(2004)
Maximum likelihood estimation of misspecified models
Econometrica
Blood glucose concentration and outcome of critical illness: The impact of diabetes
Crit Care Med
Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes
J Clin Endocrinol Metab
The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients
Infect Control Hosp Epidemiol
HbA1c and diabetes predict perioperative hyperglycemia and glycemic variability in on-pump coronary artery bypass graft patients
J Cardiothorac Vasc Anesth
Intensive insulin therapy in the critically ill patients
N Engl J Med
Current controversies around tight glucose control in critically Ill patients
Curr Opin Clin Nutr Metab Care
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
N Engl J Med
Intensive versus conventional glucose control in critically ill patients
N Engl J Med
Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data
CMAJ
Glycemic control and prevention of perioperative infection
Curr Opin Crit Care
Intensive insulin therapy in the medical ICU
N Engl J Med
Clinical experience with tight glucose control by intensive insulin therapy
Crit Care Med
Clinical review: Strict or loose glycemic control in critically ill patients–Implementing best available evidence from randomized controlled trials
Crit Care
Predisposing factors for hypoglycemia in the intensive care unit
Crit Care Med
Hypoglycemia with intensive insulin therapy in critically ill patients: Predisposing factors and association with mortality
Crit Care Med
Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support
Nutrition
Cited by (24)
Is intensive insulin therapy the scapegoat for or cause of hypoglycaemia and poor outcome?
2019, IFAC Journal of Systems and ControlGlycemic control in the intensive care unit: A control systems perspective
2019, Annual Reviews in ControlCitation Excerpt :However, poor control leading to low BG or hypoglycemia is also linked with increased mortality (Bagshaw et al., 2009; Egi et al., 2010; Finfer et al., 2012; Krinsley et al., 2011), indicating the difficulty of the control problem in regulating BG to a band. These issues clearly state any control, automated or manual, must be achieved safely, despite the high inter- and intra- patient variability in response to care (Chase, Le Compte, Suhaimi, et al., 2011; Kauffmann et al., 2011; Krinsley, Bruns, & Boyd, 2015; Langouche et al., 2007; Pielmeier, Rousing, Andreassen, Nielsen, & Haure, 2012; Pretty et al., 2012; Waeschle et al., 2008), which can define these patients. Equally, and in contrast, safe, effective control has shown equivalent association of high times in intermediate BG bands with reduced mortality (Al-Tarifi, Abou-Shala, Tamim, Rishu, & Arabi, 2011; Krinsley & Preiser, 2015; Omar et al., 2015; Penning et al., 2014; Penning et al., 2015; Signal, Le Compte, Shaw, & Chase, 2012).
A randomized controlled trial of one bag vs. two bag system of fluid delivery in children with diabetic ketoacidosis: Experience from a developing country
2018, Journal of Critical CareCitation Excerpt :Since there were no previous studies with blood glucose variability as the primary outcome variable, we planned this study as a pilot trial with a minimum of 15 children with DKA in each group i.e. control (one bag) group and experimental (two bag) group. The median absolute BG change (current BG − previous BG), standard deviation (SD) of absolute BG measurements and coefficient of variance (CV) (SD/Mean BG ∗ 100) for each patient were calculated [13,15,16]. Normally distributed continuous variables are summarized by reporting the mean and standard deviation and compared using two sample t-tests for independent samples.
Comparison of basal insulin regimens on glycemic variability in noncritically ill patients with type 2 diabetes
2015, Endocrine PracticeCitation Excerpt :In a retrospective study of a medical and surgical ICU population, Mackenzie et al (22) found that GV measured by SD, MAGE, and coefficient of variation (CV) was an independent predictor of hospital and ICU mortality. In addition, GV has been associated with increased risk of hypoglycemic events among critically ill patients (23). In the outpatient setting, higher GV has been associated with both asymptomatic and symptomatic hypoglycemia in patients with T2D (24,25).
Glycemic Variability and Glycemic Control in the Acutely Ill Cardiac Patient
2012, Heart Failure ClinicsCitation Excerpt :In hospitalized patients, glycemic variability has been associated with age, diabetes, and total insulin requirements.101 However, measures that minimize fluctuations are more likely to achieve overall glycemic control without increasing the risk of hypoglycemia.102,103 Studies in the outpatient setting suggest that physiologic insulin regimens reduce both mean glucose level and glycemic fluctuations.104–106
- 1
Presented at the Academic Surgical Congress, Huntington Beach, California, February, 2011.